Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes

Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes

Purpose: Local ablative treatment (LAT) is increasingly combined with systemic therapy in oligometastatic breast cancer (OMBC), without a high-level evidence to support this strategy. We evaluated the addition of LAT to systemic treatment in terms of progression-free survival (PFS) and overall survi...

Full description

Bibliographic Details
Main Authors: Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, Richard Aziza, Eva Jouve, Slimane Zerdoud, Eleonora De Maio, Carole Massabeau, Maxime Loo, Vincent Esteyrie, Mony Ung, Florence Dalenc, Francoise Izar, Ciprian Chira
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Breast
Subjects:
Oligometastases
Breast cancer
Local ablative treatment
Standard of care
Systemic treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977622002351

Internet

http://www.sciencedirect.com/science/article/pii/S0960977622002351

Similar Items